Pancreatic neuroendocrine neoplasm Solid pseudopapillary neoplasm Hepatocellular carcinoma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who participated in the study titled "a pilot study on the safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors" and the study titled "a study on the efficacy and safety of endoscopic ultrasound-guided radiofrequency ablation for hepatic and pancreatic tumors," and who meet the following criteria: 1. Individuals aged 18 years or older at the time of obtaining consent. 2. Individuals who, after receiving sufficient explanation regarding participation in this study, fully understood the content and voluntarily provided written informed consent
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relapse-free survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival Progression-free survival Incidence and worsening rate of diabetes mellitus Late procedure-related complications Treatment strategies for recurrent or non-curative cases | — |
Countries
Japan
Contacts
Okayama University Hospital Gastroenterology and Hepatology